Literature DB >> 22174155

Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants.

David Hongo1, Xiaobin Tang, Suparna Dutt, Roland G Nador, Samuel Strober.   

Abstract

We used a model of combined bone marrow and heart transplantation, in which tolerance and stable chimerism is induced after conditioning with fractionated irradiation of the lymphoid tissues and anti-T-cell antibodies. Graft acceptance and chimerism required host CD4(+)CD25(+) Treg production of IL-10 that was in-turn enhanced by host invariant natural killer (NK) T-cell production of IL-4. Up-regulation of PD-1 on host Tregs, CD4(+)CD25(-) conventional T (Tcon) cells, and CD8(+) T cells was also enhanced by NKT cell production of IL-4. Up-regulated PD-1 expression on Tregs was linked to IL-10 secretion, on CD8(+) T cells was linked to Tim-3 expression, and on CD4(+) Tcon cells was associated with reduced IFNγ secretion. Changes in the expression of PD-1 were induced by the conditioning regimen, and declined after bone marrow transplantation. In conclusion, NKT cells in this model promoted changes in expression of negative costimulatory receptors and anti-inflammatory cytokines by Tregs and other T-cell subsets in an IL-4-dependent manner that resulted in tolerance to the bone marrow and organ grafts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22174155      PMCID: PMC3286219          DOI: 10.1182/blood-2011-08-371948

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+ CD25+ T cells.

Authors:  Soren Schenk; Danielle D Kish; Chunshui He; Tarek El-Sawy; Eise Chiffoleau; Chuangqi Chen; Chuangqui Chen; Zihao Wu; Sigrid Sandner; Anton V Gorbachev; Kiyotaka Fukamachi; Peter S Heeger; Mohamed H Sayegh; Laurence A Turka; Robert L Fairchild
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

2.  Activated CD1d-restricted natural killer T cells secrete IL-2: innate help for CD4+CD25+ regulatory T cells?

Authors:  Shuiping Jiang; David S Game; Derek Davies; Giovanna Lombardi; Robert I Lechler
Journal:  Eur J Immunol       Date:  2005-04       Impact factor: 5.532

Review 3.  Toward an understanding of NKT cell biology: progress and paradoxes.

Authors:  Mitchell Kronenberg
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 4.  Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.

Authors:  Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

5.  Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia.

Authors:  Ruolan Liu; Antonio La Cava; Xue-Feng Bai; Youngheun Jee; Mary Price; Denise I Campagnolo; Premkumar Christadoss; Timothy L Vollmer; Luc Van Kaer; Fu-Dong Shi
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

6.  Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells.

Authors:  Daigo Hashimoto; Shoji Asakura; Sachiko Miyake; Takashi Yamamura; Luc Van Kaer; Chen Liu; Mitsune Tanimoto; Takanori Teshima
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

7.  Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

Authors:  J Cui; T Shin; T Kawano; H Sato; E Kondo; I Toura; Y Kaneko; H Koseki; M Kanno; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

Review 8.  Mouse CD1-specific NK1 T cells: development, specificity, and function.

Authors:  A Bendelac; M N Rivera; S H Park; J H Roark
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

9.  Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo.

Authors:  Sigrid E Sandner; Michael R Clarkson; Alan D Salama; Alberto Sanchez-Fueyo; Christoph Domenig; Antje Habicht; Nader Najafian; Hideo Yagita; Miyuki Azuma; Laurence A Turka; Mohamed H Sayegh
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

10.  A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance.

Authors:  Masaki Terabe; Jeremy Swann; Elena Ambrosino; Pratima Sinha; Shun Takaku; Yoshihiro Hayakawa; Dale I Godfrey; Suzanne Ostrand-Rosenberg; Mark J Smyth; Jay A Berzofsky
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

View more
  40 in total

Review 1.  Lymphodepletional strategies in transplantation.

Authors:  Eugenia Page; Jean Kwun; Byoungchol Oh; Stuart Knechtle
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

2.  Association of peripheral NK cell counts with Helios+ IFN-γ- Tregs in patients with good long-term renal allograft function.

Authors:  K Trojan; L Zhu; M Aly; R Weimer; N Bulut; C Morath; G Opelz; V Daniel
Journal:  Clin Exp Immunol       Date:  2017-03-13       Impact factor: 4.330

3.  Ly108 expression distinguishes subsets of invariant NKT cells that help autoantibody production and secrete IL-21 from those that secrete IL-17 in lupus prone NZB/W mice.

Authors:  Xiaobin Tang; Bo Zhang; Justin A Jarrell; Jordan V Price; Hongjie Dai; Paul J Utz; Samuel Strober
Journal:  J Autoimmun       Date:  2014-02-07       Impact factor: 7.094

Review 4.  Path to clinical transplantation tolerance and prevention of graft-versus-host disease.

Authors:  Samuel Strober
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

5.  Requirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance.

Authors:  D Hongo; X Tang; J Baker; E G Engleman; S Strober
Journal:  Am J Transplant       Date:  2014-10-13       Impact factor: 8.086

6.  Tolerogenic interactions between CD8+ dendritic cells and NKT cells prevent rejection of bone marrow and organ grafts.

Authors:  David Hongo; Xiaobin Tang; Xiangyue Zhang; Edgar G Engleman; Samuel Strober
Journal:  Blood       Date:  2017-01-17       Impact factor: 22.113

Review 7.  The immunoregulatory role of type I and type II NKT cells in cancer and other diseases.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Cancer Immunol Immunother       Date:  2014-01-03       Impact factor: 6.968

8.  Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host disease.

Authors:  Abel Trujillo-Ocampo; Hyun-Woo Cho; Amanda C Herrmann; Wilfredo Ruiz-Vazquez; Andrew B Thornton; Hong He; Dan Li; Mariam A Qazilbash; Qing Ma; Steven A Porcelli; Elizabeth J Shpall; Jeffrey Molldrem; Jin S Im
Journal:  Cytotherapy       Date:  2018-07-31       Impact factor: 5.414

Review 9.  Immune tolerance and transplantation.

Authors:  Onder Alpdogan; Marcel R M van den Brink
Journal:  Semin Oncol       Date:  2012-12       Impact factor: 4.929

10.  Regulatory T Cell Immunotherapy in Immune-Mediated Diseases.

Authors:  Antonio Pierini; Dominik Schneidawind; Hidekazu Nishikii; Robert S Negrin
Journal:  Curr Stem Cell Rep       Date:  2015-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.